Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis
暂无分享,去创建一个
Y. Miao | elliot k fishman | E. Thompson | Jun Yu | L. Yin | N. Pu
[1] J. Cameron,et al. Recurrence in Patients Achieving Pathological Complete Response After Neoadjuvant Treatment for Advanced Pancreatic Cancer. , 2019, Annals of surgery.
[2] Y. Miao,et al. Advances of pathological complete response after neoadjuvant therapy for pancreatic cancer , 2019, Journal of Pancreatology.
[3] A. Maitra,et al. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer. , 2019, Gastroenterology.
[4] M. Makary,et al. Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status: Results of the Prospective CLUSTER Study , 2018, Annals of surgery.
[5] I. Esposito,et al. Pathology assessment of pancreatic cancer following neoadjuvant treatment: Time to move on. , 2018, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].
[6] M. Makary,et al. Is a Pathological Complete Response Following Neoadjuvant Chemoradiation Associated With Prolonged Survival in Patients With Pancreatic Cancer? , 2018, Annals of surgery.
[7] T. Pawlik,et al. 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers , 2018, Annals of Surgical Oncology.
[8] Song Gao,et al. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer , 2017, International journal of molecular sciences.
[9] C. Compton,et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.
[10] J. Cameron,et al. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma , 2016, Annals of surgery.
[11] Jeffrey E. Lee,et al. Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma , 2012, Cancer.
[12] A. Renshaw,et al. Protocol for the examination of specimens from patients with carcinoma of the penis. , 2010, Archives of pathology & laboratory medicine.
[13] Michael B Farnell,et al. Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival. , 2010, Archives of surgery.
[14] M. Ychou,et al. Histopathological Response to Preoperative Chemoradiation for Resectable Pancreatic Adenocarcinoma: The French Phase II FFCD 9704-SFRO Trial , 2008, American journal of clinical oncology.
[15] E. Paulson,et al. Significance of Histological Response to Preoperative Chemoradiotherapy for Pancreatic Cancer , 2005, Annals of Surgical Oncology.
[16] F. Ames,et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. , 1992, Archives of surgery.
[17] T. Teshima,et al. Clinical and histopathological appraisal of preoperative irradiation for adenocarcinoma of the pancreatoduodenal region , 1989, Journal of surgical oncology.
[18] A. Jemal,et al. Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.
[19] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.